Evaluation of ultrafiltrated fluid overloaded patients: a single center study

Year 2023, , 247 - 252, 28.07.2023

Özgür Can , Süleyman Baş , Gülizar Manga Şahin , Süheyla Apaydın

https://doi.org/10.38053/acmj.1254921

Abstract

Aims: Fluid overloaded patients with heart or renal insufficiency have poor quality of life and increased morbidity and mortality. In this study, we aimed to investigate the factors affecting the prognosis in patients who presented with fluid overload and were ultrafiltered.
Methods: Three groups of patients were compared: Group 1: Patients with chronic kidney disease and ejection fraction ≤ 40%; Group 2: Patients with chronic kidney disease and ejection fraction > 40%; Group 3: Patients with ejection fraction ≤ 40% but without chronic kidney disease. Patients were also evaluated regarding mortality.
Results: Group 1, 2 and 3 consisted of 14, 62 and 16 patients: respectively. There were statistically significant results for 24-hour urine volume (p=0.040), proteinuria (p=0.010), ultrafiltration volume/weight at hospitalization (p<0.001), ejection fraction (p<0.001), left ventricular hypertrophy (p=0.040), uric acid (p<0.001), hemoglobin (p<0.001), dialysis dependency after hospital discharge (p<0.001) and mortality (p<0.001) when three groups were compared. However, there was no statistically significant result for ultrafiltration volume (p=0.100). Compared to survived patients those who did not survived were significantly older (p<0.001), had lower ejection fraction (p=0.010), creatinine (p<0.001), sodium (p=0.020), ferritin (p=0.040), proteinuria (p=0.010). They also had statistically significantly higher hemoglobin (p<0.001), creatinine clearance (p<0.001), uric acid (p<0.001) levels. However, the percentage of patients using loop diuretics at hospitalization (p=0.040) was higher in the group who survived.
Conclusion: Patients with HF were more prone to hypervolemia and mortality. The ultrafiltration volume/weight at hospitalization and serum uric acid levels were also significantly higher in these patients. Patients with chronic kidney disease had significantly higher proteinuria, creatinine and lower hemoglobin levels. The rate of loop diuretic usage at hospitalization was significantly higher in the survived group.

Keywords

Dialysis, ejection fraction, heart failure, loop diuretics, left ventricular hypertrophy, mortality, ultrafiltration

Project Number

Yoktur

References

• Costanzo MR, Guglin ME, Saltzberg MT, et al. UNLOAD Trial Investigators. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2007;49:675-683.
• Marenzi G, Grazi S, Giraldi F, et al. Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure:effects of extracorporeal ultrafiltration. Am J Med. 1993;94:49-56.
• Marenzi G, Lauri G, Grazi M, Assanelli E, Campodonico J, Agostoni P. Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol. 2001;38:963-968.
• Cipolla CM, Grazi S, Rimondini A, et al. Changes in circulating norepinephrine with hemofiltration in advanced congestive heart failure. Am J Cardiol. 1990;66:987-994.
• Agostoni PG, Guazzi M, Bussotti M, Grazi M, Palermo P, Marenzi G. Lack of improvement of lung diffusing capacity following fluid withdrawal by ultrafiltration in chronic heart failure. J Am Coll Cardiol. 2000;36:1600-1604.
• Giglioli C, Landi D, Cecchi E, et al. Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO study. Eur J Heart Fail. 2011;13:337-346.
• Zoccali C, Mallamaci F. The chronology of the clinical cardiorenal links and health outcomes: problematic issues of the cardiorenal syndrome construct. Nephrol Dial Transplant. 2022;37:2300-2302.
• 8.Ruocco G, Palazzuoli A. Hyperuricemia in US population with heart failure: causal or incidental bystander? Cardiorenal Med. 2019;9:341-343.
• Kuwabara M. Hyperuricemia, cardiovascular disease, and hypertension. Pulse (Basel). 2016;3:242-252.
• Reyes AJ. The increase in serum uric acid concentration caused by diuretics might be beneficial in heart failure. Eur J Heart Fail. 2005;7:461-7.
• Teodosiev L. Excretion of uric acid in cardiac decompensation. Vutr Boles. 1979;18:218-224.
• Borghi C, Cosentino ER, Rinaldi ER, Cicero AF. Uricaemia and ejection fraction in elderly heart failure outpatients. Eur J Clin Invest. 2014;44:573-578.
• Huang H, Huang B, Li Y, et al. Uric acid and risk of heart failure:a systematic review and meta-analysis. Eur J Heart Fail. 2014;16:15-24.
• Jørgensen ME, Andersson C, Vasan RS, Køber L, Abdulla J. Characteristics and prognosis of heart failure with improved compared with persistently reduced ejection fraction: a systematic review and meta-analyses. Eur J Prev Cardiol. 2018;25:366-376.
• Albright R, Brensilver J, Cortell S. Proteinuria in congestive heart failure. Am J Nephrol. 1983;3:272-275.
• Stauffer ME, Fan T. Prevalence of anemia in chronic kidney disease in the United States. PLoS One. 2014;9:e84943.
• Di Lullo L, Floccari F, Polito P. Right ventricular diastolic function in dialysis patients could be affected by vascular access. Nephron Clin Pract. 2011;118:c257-261.
• Aoki J, Ikari Y, Nakajima H, et al. Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients. Kidney Int. 2005;67:333-340.
• Levin A. Anemia and left ventricular hypertrophy in chronic kidney disease populations:a review of the current state of knowledge. Kidney Int Suppl. 2002;80:35-38.
• Siddiqui WJ, Kohut AR, Hasni SF, et al. Readmission rate after ultrafiltration in acute decompensated heart failure: a systematic review and meta-analysis. Heart Fail Rev. 2017;22:685-698.
• Grodin JL, Carter S, Bart BA, Goldsmith SR, Drazner MH, Tang WHW. Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF. Eur J Heart Fail. 2018;20:1148-1156.
• Srivastava M, Harrison N, Caetano AFS, Tan AR, Law M. Ultrafiltration for acute heart failure. Cochrane Database Syst Rev. 2022;1:CD013593.
• Dev S, Shirolkar SC, Stevens SR, et al. Reduction in body weight but worsening renal function with late ultrafiltration for treatment of acute decompensated heart failure. Cardiology. 2012;123:145-153.
• Liang KV, Hiniker AR, Williams AW, Karon BL, Greene EL, Redfield MM. Use of a novel ultrafiltration device as a treatment strategy for diuretic resistant, refractory heart failure:initial clinical experience in a single center. J Card Fail. 2006;12:707-714.
• Cooperman LH, Price HL. Pulmonary edema in the operative and postoperative period:a review of 40 cases. Ann Surg. 1970;172:883-891.
• Stein A, de Souza LV, Belettini CR, et al. Fluid overload and changes in serum creatinine after cardiac surgery: predictors of mortality and longer intensive care stay. a prospective cohort study. Crit Care. 2012;16:R99.
• Ip JE, Cheung JW, Park D, et al. Temporal associations between thoracic volume overload and malignant ventricular arrhythmias:a study of intrathoracic impedance. J Cardiovasc Electrophysiol. 2011;22:293-299.